Abstract
Introduction
B lymphopoiesis in the bone marrow is an organized process that proceeds through a number of developmental checkpoints. Distinct stages of differentiation can be defined by the expression of cell surface molecules as well as by changes in the configuration of the Ig gene loci (1-3). Expression of the pre-B receptor complex, composed of µ Ig heavy chains, λ5 plus v-pre-B surrogate light chains and mb-1 (Igα) plus B29 (Igβ) co-receptors is essential for transition from the pro-B to the pre-B cell stage. Progression from the pre-B stage to the mature B cell stage requires expression of Ig heavy chains and Ig light (κ or λ) chains (2, 3) .
IL-7 and its receptor (IL-7R) also play a critical role in B cell development. IL-7 was originally identified and cloned as a cytokine which induced proliferation of B cell progenitors in the absence of stromal cells (4, 5) . Subsequently it was found that IL-7 can also promote survival and growth of T cell progenitors and mature T lymphocytes (6) (7) (8) (9) . IL-7 stimulates Similar defects are observed in mice lacking the IL-2R γ c chain (22) or the Jak-3 signal transducing kinase (23) . These results demonstrate that high affinity IL-7R/γ c signaling via Jak-3 is essential for the development and expansion of B cell progenitors during the stage of Ig heavy chain gene rearrangement and for production of pro-T cells prior to the onset of TCR β gene rearrangement.
These defects could be a consequence of reduced cell proliferation, impaired differentiation or increased cell death. The IL-7R and the anti-apoptotic protein Bcl-2 are coexpressed in B and T lymphopoiesis: both are expressed in pro-B cells and pro-T cells as well as in mature B cells and T cells, but are undetectable in pre-B cells (B220 ϩ sIg -CD43 -) and pre-T cells (CD4 ϩ CD8 ϩ ) (1,4). IL-7R stimulation may directly regulate expression of Bcl-2 since Bcl-2 levels are abnormally low in pro-T cells from IL-7 -/-mice but can be restored to normal upon culture of these cells in IL-7 (27) . Transgenic expression of Bcl-2 rescues T cell development and T cell function in IL-7R -/-mice (28, 29) and in mutant mice lacking the γ c chain (30) . These findings indicate that the essential function of IL-7R/γ c signaling during T lymphopoiesis is to inhibit apoptosis to facilitate continued cell expansion and differentiation.
It is unclear whether IL-7R/γ c signaling during B lymphopoiesis is essential for cell division, cell differentiation, cell survival or a combination thereof. Expression of a bcl-2 transgene is incapable of rescuing B cell development in mutant mice lacking the IL-2R γ c chain (30) . To investigate the role of IL-7R-transduced anti-apoptotic signaling during B lymphopoiesis, we examined the consequence of enforced expression of Bcl-2 on B cell development in IL-7R -/-mice. Our analysis revealed that Bcl-2 overexpression is incapable of rescuing impaired B lymphopoiesis in IL-7R -/-mice but can enhance survival of peripheral B cells which have escaped the developmental arrest. Thus, in contrast to the case of T cell differentiation, Bcl-2 overexpression cannot substitute for IL-7R signaling during B cell development. These results have implications for the role of IL-7R signaling in the control of cell division, differentiation and apoptosis during B lymphopoiesis.
Methods

Mice
The IL-7R -/-mice (20) , the E µ -bcl-2-36 transgenic mice (31) , which constitutively express a human bcl-2 cDNA at high levels in B and T lineage cells, and the bcl-2/IL-7R -/-mice (29) have been previously described. Mice were bred under specific pathogen-free conditions and used at 6-8 weeks of age. Inheritance of the bcl-2 transgene and the mutant or wild-type IL-7R allele were identified by genomic Southern blot or PCR analyses (20, 31) .
Preparation of cell suspensions
Spleen cell suspensions were prepared by disruption of the tissue between glass slides in PBS containing 5% heatinactivated FBS (PBS/FBS) and cells were counted in a hemocytometer. Cell suspensions from bone marrow were obtained by flushing both femora and tibiae with PBS/FBS, and cells were counted as described above. Erythrocytes were removed by lysis in NH 4 Cl. Blood was obtained by terminal cardiac puncture and serum was collected after coagulation in non-heparinized tubes.
Immunofluorescence staining and flow cytometric analysis All flow cytometric analysis of bone marrow cells and spleen cells was performed by incubating with directly conjugated mAb (PharMingen, San Diego, CA) and analysis was performed with a FACStar Plus (Becton Dickinson, Sunnyvale, CA) as previously described (20) . Bone marrow cells were incubated with the following list of mAb: anti-IgM-Texas Red, anti-B220-phycoerythrin (PE), anti-HSA-FITC and anti-HSAbiotin which was revealed by streptavidin-allophycocyanin (APC). Spleen cells were incubated with anti-IgM-Texas Red, anti-B220-PE, anti-IgD-FITC and anti-CD23-biotin, which was revealed by streptavidin-APC. Staining was performed in the presence of 50 µg/ml 2.4G2 anti-FcγRII mAb to block nonspecific binding of antibodies and 10 µg/ml propidium iodide was added to exclude dead cells from analysis.
B cell colony-forming assay (CFU-B)
Bone marrow leukocytes were counted using Tuerk's solution, and then plated in methylcellulose (M3230; Stem Cell Technologies, Vancouver, BC) containing 50 U/ml penicillin, 50 µg/ ml streptomycin and 2 mM glutamine (JRH Biosciences, Lenexa, KS). Cells were plated at a density of 1ϫ10 5 cells/ ml and stimulated with 50 ng/ml recombinant human IL-7 (Immunex, Seattle, WA) or 200 ng/ml recombinant mouse Kit ligand (KL) (Immunex). Cultures stimulated with both cytokines contained 5ϫ10 4 cells/ml. Cells were plated at limiting dilution in 24-well plates (Costar, Cambridge, MA) in a volume of 0.5 ml. Four to eight wells were plated per sample. Plates were incubated in a 37°C, 5% CO 2 incubator. After 7 days colonies containing Ͼ50 cells were scored. To harvest colonies for phenotyping by flow cytometry, 1 ml of PBS was added per well, and after 30 min cells were collected, and centrifuged at 2000 r.p.m. for 10 min. Cells were resuspended in ice-cold FACS buffer (PBS containing 2% FBS and 0.02% sodium azide) and incubated with the following mAb: anti-B220-PE plus anti-CD11b-FITC combined with anti-Gr-1-FITC. Rat IgG2a-PE and rat IgG2b-FITC were used as isotype-matched controls (PharMingen).
Mitogenic stimulation of splenic B cells in tissue culture
Erythrocyte-depleted spleen cells (5ϫ10 7 ) were incubated for 20 min with a cocktail of the following antibodies: anti-Thy-1, anti-CD4, anti-CD8, anti-NK1.1, anti-CD11b, anti-Ter119 and anti-Gr-1 (PharMingen). After washing in PBS/FBS, the antibody-coated cells were removed by adherence to sheep antirat Ig antibody-coated magnetic beads (Dynal, Oslo, Norway). The enriched B cell population was 85-92% pure as assessed by immunofluorescence staining and FACS analysis. These enriched B cells were cultured at a density of 5ϫ10 4 cells/ well in 96-well round-bottomed trays in RPMI medium containing 10% FBS and 50 mM 2-mercaptoethanol. Cells were stimulated with 1 µg/ml CD40 ligand (Immunex), and 20 ng/ ml of each of the cytokines IL-2, IL-4 and IL-5 (Genzyme, Cambridge, MA). After 2 days incubation at 37°C in a 5% CO 2 incubator, one set of cultures was pulsed for 8 h with 0.5 µCi 
a Numbers of bone marrow cells in the bone marrow in each mouse group harvested from bilateral tibiae and femurs. Results represent the mean Ϯ SD of five separate experiments from a total of 15-20 mice per group.
were harvested onto glass fiber filters and [ 3 H]thymidine incorporation was assessed using a gas-phase β scintillation counter. The supernatants from the remaining duplicate set of cultures were harvested after 6 days and examined by ELISA (Southern Biotechnology Associates, Birmingham, AL) for the presence of total IgM, IgG1 and IgG2a antibodies.
Results and discussion
Expression of a bcl-2 transgene does not rescue B cell development in IL-7R -/-mutant mice We (28) and others (29) have previously shown that expression of a bcl-2 transgene rescues T lymphopoiesis and T cell function in IL-7R -/-mice. The bcl-2 transgene used in our experiments, E µ -bcl-2-36, is expressed in both lymphoid lineages (31) , with pro-B cells in the bone marrow expressing higher levels than pro-T cells in the thymus (32, 33) . We could therefore use our existing bcl-2/IL-7R -/-mice to investigate the effect of Bcl-2 overexpression on differentiation of IL-7R-deficient B cells. For comparison we analyzed wild-type (IL-7R ϩ/ϩ ) mice, bcl-2 transgenic (IL-7R ϩ/ϩ ) mice and IL-7R -/-mice. IL-7R -/-mice exhibit two distinct phenotypes with respect to thymus cellularity:~65% have thymii that are composed almost exclusively of CD3 -CD4 -CD8 -pro-T cells with a total cellularity of Ͻ1% compared to normal mice (IL-7R -/-Ͻ1%) while the other~35% have detectable numbers of CD3 ϩ CD4 ϩ CD8 ϩ pre-T cells and a thymic cellularity ranging between 1 and 10% of normal mice (IL-7R -/-Ͼ1%) (28, 34) . These two groups of mice do not differ with respect to their defect in B lymphopoiesis and data from all IL-7R -/-mice were therefore pooled.
Flow cytometric analysis of the composition of B lineage cells in the bone marrow of the above listed mouse strains is shown in Fig. 1 and a summary of the absolute numbers of the B cell subpopulations is presented in Table 1 . IL-7R -/-mice have on average 3-fold fewer bone marrow leukocytes compared to wild-type animals and the numbers of sIgM ϩ B cells are reduced by~20-to 50-fold (Table 1 ). The numbers of B220 ϩ sIgM -B cell precursors were reduced by~5-fold in IL-7R -/-mice (Table 1) . Consistent with previous observations (35, 36) , bcl-2 transgenic (IL-7R ϩ/ϩ ) mice had a 2-fold increase in sIgM ϩ B cells in bone marrow (Table 1) . However, expression of the bcl-2 transgene in IL-7R -/-mice did not increase the frequencies (Fig. 1a) or absolute numbers (Table 1) of sIgM ϩ B220 ϩ B cells or sIgM -B220 ϩ B cell precursors. To examine in greater detail the stage at which B cell development is affected in IL-7R -/-mice, the B220 ϩ sIgMprecursor population was further separated on the basis of CD43 and HSA expression (Fig. 1b) . According to the model of B cell differentiation proposed by Hardy et al. Table 1 ). Consistent with previous observations (35, 36) , bcl-2 transgenic (IL-7R ϩ/ϩ ) mice had normal numbers of pro-B cells and pre-B cells (Fig. 1b and Table 1 ). Our analysis revealed that there was no significant difference in the numbers of pro-B cells and pre-B cells between bcl-2/IL-7R -/-mice and IL-7R -/-mice (Table 1 ).
These results demonstrate that constitutive Bcl-2 expression is incapable of rescuing B lymphopoiesis in IL-7R -/-mice. It therefore appears that the essential role of IL-7R signaling is not to block a Bcl-2-inhibitable pathway to apoptosis, but may rather be to promote cell proliferation.
Expression of a bcl-2 transgene does not rescue impaired colony formation of IL-7R -/-B cell progenitors B cell progenitors can be cultured in liquid medium, agar or methylcellulose in the presence of soluble cytokines and/or signals from stromal cells (1, [37] [38] [39] . During differentiation the stimulatory requirements for B cell growth change. The most primitive pro-B cells require a stromal cell factor, either KL or Flt3 ligand (FL), plus IL-7 for maximal colony formation to occur and responsiveness to IL-7 is lost at the transition from the pro-B to the pre-B cell stage (38) . It is unclear whether in this B lymphocyte culture system IL-7 is essential for mediating proliferation, blocking apoptosis or both. To investigate this question, we tested the ability of B cell progenitors from IL-7R -/-mice and bcl-2/IL-7R -/-mice to form colonies in methylcellulose after stimulation with either IL-7 alone or with IL-7 plus KL. Unlike bone marrow cells from control (IL-7R ϩ/ϩ ) mice and bcl-2 transgenic mice, bone marrow cells from IL-7R -/-mice and bcl-2/IL-7R -/-mice were unable to form B cell colonies in the presence of IL-7 alone (Fig. 2a) . Interestingly, significant numbers of colonies were detected when bone marrow cells from either IL-7R -/-mice or bcl-2/IL-7R -/-mice were cultured in the presence of IL-7 plus KL. However, phenotypic analysis of these cells revealed that they were predominantly of myeloid origin (B220 -CD11b ϩ Gr-1 ϩ ) (Fig.  2b) and colonies of this type were also formed with similar frequency when cells were stimulated with KL alone (data not shown).
These results demonstrate that the deficient capacity of bone marrow cells from IL-7R -/-mice to form B cell colonies could not be rescued by constitutive expression of Bcl-2. This is consistent with the notion that the essential role of IL-7R stimulation in B cell progenitor growth cannot be to inhibit a Bcl-2-blockable pathway to apoptosis, but is more likely to provide a proliferative signal.
Expression of a bcl-2 transgene leads to an increase in the number of B cells in peripheral lymphoid organs of IL-7R -/-mice As previously reported (20) , IL-7R -/-mice have abnormally low splenic cellularity (3-to 5-fold reduced compared to control mice). Expression of a bcl-2 transgene restores normal T lymphocyte cellularity in spleens of IL-7R -/-mice (Table 2 ) (28, 29) . Flow cytometric analysis revealed that IL-7R -/-mice also had reduced numbers of mature B220 ϩ B cells (Fig. 3a and Table 2 ). A substantial proportion of these B220 ϩ spleen cells were sIgM -CD19 -NK1.1 -suggesting the accumulation of a population of immature B cells (Fig. 3a , Table 2 and data not shown). Consistent with this notion, the majority of splenic B220 ϩ sIgM -cells in IL-7R -/-mice expressed low to undetectable levels of sIgD, lower levels of the mature B cell marker CD23 and unusually high levels of HSA (Fig. 3b and data not shown). The absolute numbers of all B220 ϩ B cells and of B220 ϩ sIgM ϩ B cells were significantly increased (~6-to 7-fold respectively) in the spleens of bcl-2/IL-7R -/-mice as compared to IL-7R -/-mice ( Fig. 3 and Table 2 ). Interestingly, there was also a large increase (~7-fold) in the absolute numbers of immature sIgM -B cells in the spleens of bcl-2/ IL-7R -/-mice as compared to IL-7R -/-mice ( Fig. 3 and Table  2 ). As in IL-7R -/-mice, the majority of B220 ϩ sIgM ϩ B cells accumulating in bcl-2/IL-7R -/-mice were sIgD -and expressed lower levels of CD23 (Fig. 3b) . This is reminiscent of previous results showing that expression of a bcl-2 transgene results in the accumulation of B220 ϩ sIgM -B cells in the periphery of mutant scid, rag-1 -/-, rag-2 -/-and µMT/µMT mice (33, 40, 41) .
In summary, these results are consistent with the notion that Bcl-2 is incapable of rescuing the defect in B lymphopoiesis in IL-7R -/-mice but can enhance survival of those B cells that escaped developmental arrest, thus leading to their accumulation in peripheral lymphoid organs.
B cells from IL-7R -/-mice and bcl-2/IL-7R -/-mice respond normally to mitogenic stimulation
The rare mature T cells that accumulate in peripheral lymphoid organs of IL-7R -/-mice are functionally impaired. They exhibit a slower rate of proliferation and an increased rate of apoptotic death after mitogenic stimulation in tissue culture (34) . Interestingly, although B cells were reduced~10-fold in number in IL-7R -/-mice and a significant proportion of them were phenotypically immature (sIgM -sIgD -CD23 low ), no significant difference in the total levels of IgM and IgG 1 were observed in the serum of either IL-7R -/-or bcl-2/IL-7R -/-mice compared with control IL-7R ϩ/ϩ mice (Fig. 4a) . This indicated that the mature B cells present in IL-7R -/-mice were functionally competent, at least with respect to their ability to mature into Ig-secreting plasma cells. To investigate in detail the functional capacity of B lymphocytes in IL-7R -/-mice, we analyzed their response in culture to mitogenic stimulation with CD40 ligand plus IL-2, IL-4 and IL-5. Cell proliferation was measured after 2 days by determining the rate of [ 3 H]thymidine incorporation and Ig secretion was examined by ELISA after 6 days. B cells from IL-7R -/-mice proliferated at a rate comparable to normal (IL-7R ϩ/ϩ ) B cells (Fig. 5a) . Furthermore, IL-7R -/-B cells produced similar amounts of IgM, IgG1 and IgG2a compared to control (IL-7R ϩ/ϩ ) B cells (Fig. 5b) . These results demonstrate that IL-7R signaling is not essential for mitogenic responses of mature B lymphocytes.
In conclusion, these results demonstrate that IL-7R-signaling must have a different role in B cell development than in T cell development; Bcl-2 can rescue the defect in T lymphopoiesis (28, 29) but not the defect in B lymphopoiesis (this paper) despite the higher levels of transgene-encoded Bcl-2 protein in pro-B cells (32, 33) . Consistent with these results, expression of a bcl-2 transgene promoted T lymphopoiesis but not B lymphopoiesis in γ c chain-deficient mice (30) . Thus, the essential role of IL-7R and γ c chain signaling in T lymphopoiesis appears to inhibit apoptosis by a mechanism that can be replaced by Bcl-2 overexpression. But what is the essential role of IL-7R and γ c chain signaling in B lymphopoiesis? It is unlikely to be an obligate requirement for cell differentiation, since some mature B cells can develop in mice lacking IL-7, IL-7R or γ c chain (20) (21) (22) . It is more likely that the essential role of IL-7R signaling in B lymphoid progenitors is to promote cell proliferation, a function that cannot be replaced by Bcl-2. In fact, cell cycle progression can in certain conditions be slowed by Bcl-2 or its homologues (42) (43) (44) . Since B cell progenitors that failed to differentiate do not accumulate in bone marrow of mice lacking IL-7, IL-7R or the γ c chain (20) (21) (22) , even when they express a bcl-2 transgene (this paper and 30), these cells must succumb to a Bcl-2-insensitive pathway of cell elimination. This may involve activation of members of the tumor necrosis factor receptor family (45) .
The results also reveal a surprising difference between B lymphopoiesis and T lymphopoiesis. Bcl-2 can rescue B lineage cells that fail to receive signals from the pre-B cell receptor (33, 40, 41) but cannot rescue those that fail to receive signals from the IL-7R/γ c receptor complex (this paper and 30). In contrast, in T lymphopoiesis Bcl-2 can rescue those cells that lack signals from the IL-7R/γ c receptor complex (28) (29) (30) but not those that fail to express the pre-TCR (29, 40) .
